KOSS vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 19, 2026

KOSS

51.0
AI Score
VS
CLOV Wins

CLOV

54.8
AI Score

Investment Advisor Scores

KOSS

51score
Recommendation
HOLD

CLOV

55score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric KOSS CLOV Winner
Revenue 5.78M 749.19M CLOV
Net Income 41,570 27.33M CLOV
Net Margin 0.7% 3.6% CLOV
Operating Income 41,595 27.33M CLOV
ROE 0.3% 8.1% CLOV
ROA 0.2% 3.9% CLOV
Total Assets 22.62M 697.73M CLOV
Current Ratio 4.21 1.33 KOSS
Free Cash Flow 692,999 107.04M CLOV

Relative Price Performance (Last 90 Days)

KOSS 1M: -6.0% · 3M: -14.4% CLOV 1M: -17.7% · 3M: +59.8%

Current Technical Phase

KOSS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.5%), weak momentum, RSI 45

RSI (14): 44.9 · Price: $3.73

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.7 · Price: $4.33

Fundamentals Snapshot

Metric KOSS CLOV
Market Cap
Forward P/E 526.3 43.3
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.6%
Gross Margin 0.4% 0.2%
Operating Margin -0.3% 0.0%
EPS -0.11 -0.12
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CLOV is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.